As the vaccine rollout continues across America, families are wondering when their children will be eligible for inoculation against COVID-19. Dr. Juan Salazar, M.D, physician-in-chief at the Connecticut Children s Medical Center.
Heffner column: Time for fathers
Dr. Elaine Heffner
Columns share an author’s personal perspective.
“But he’s a human being, and a terrible thing is happening to him. So attention must be paid. … Attention, attention must be finally paid to such a person.” This quote, from Arthur Miller’s “Death of a Salesman,” is spoken by the mother in the play, about the father. These days, the quote should read “a terrible thing is happening to her,” as attention must finally be paid to the mother.
Mothers are paying a terrible price for the consequences of the pandemic. When schools shut down, it was mothers primarily who were making lists and schedules, searching for activities to keep children occupied, supervising online education, while at the same time keeping up at home with their own paid work and household responsibilities. Although many fathers were also working from home, mothers knew it would be up to them to figure out how to do three jobs at once - par
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Nation’s Top Orthopedic Hospital Launches the First FDA Approved Digital Pathology Platform
February 9, 2021 GMT
HSS Logo (PRNewsfoto/Hospital for Special Surgery)
NEW YORK, Feb. 9, 2021 /PRNewswire/ Hospital for Special Surgery (HSS), the world’s leading academic medical center specializing in orthopedics, rheumatology, and related disciplines, has become the first facility in the country to launch a cutting-edge technology for the digitization of pathology slides allowing pathologists to use digital images as primary means of diagnosis.
The system, called the Sectra Digital Pathology Solution, lets HSS pathologists scan and upload slides into a single repository where others in the care team from orthopedic surgeons and radiologists to rheumatologists and endocrinologists can view them, along with radiologic images that also are housed in the system. This facilitates access fo
Press release content from Business Wire. The AP news staff was not involved in its creation.
NOXXON Appoints Leading Pancreatic Cancer Experts to Scientific Advisory Board
February 8, 2021 GMT
Regulatory News:
NOXXON Pharma N.V.
(Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today the appointment of four leading pancreatic cancer experts to its Scientific Advisory Board (SAB). Led by the newly appointed Chair, Dr. Jose Saro, the SAB will provide strategic and scientific counsel to NOXXON’s clinical programs in this indication.
“These prominent research leaders bring long-standing clinical expertise, cutting-edge scientific knowledge, and a track record of successfully developing new drugs to treat this devastating disease. They fully understand the challenges of developing new drugs for pancreas cancer where the tumor microenvironment plays a large role in resisting ant